Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
May 16, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for July 13, 2006 Subscribe to this News Feed      
 

MEMS and Nanotechnology Providing Real Solutions for the Management of Diabetes, Reports Bourne Research

The management of Diabetes is being made easier through the use of next-generation technologies such as MEMS and Nanotechnology.

Scottsdale, AZ (PRWEB) July 13, 2006 -- During the first half of 2006, there was a noticeable upswing in activity focused on the development of MEMS (MicroElectroMechanical Systems) and Nanotechnology-based solutions for the care and management of Diabetes, according to Bourne Research (www.bourneresearch.com). The market research firm reports that a variety of MEMS devices, nanostructures and other emerging technologies are not only being tapped for blood glucose monitoring and insulin delivery, but for other Diabetes-related complications as well, including those related to the eyes and gastrointestinal tract.

“What’s most notable about the current round of products in development, in clinical trials, or recently approved by the FDA and launched into the market is that many are wireless, implantable or both,” says Marlene Bourne, President & Principal Analyst with Bourne Research. “While these approaches will make living with and managing Diabetes much easier, they are also highlighting a very real need for next-generation battery technologies, which are in development.”

Bourne Research reports that even though a few large firms dominate the Diabetes market, it remains very attractive for start-ups with innovative ideas, since this segment has historically been at the forefront of acquisition activity. The firm notes that five companies have received nearly $80 million in venture capital funding in the past few months, and an acquisition is pending.

More details about the use of MEMS and Nanotechnology for the management of Diabetes can be found in The Bourne Report – Medical Device Quarterly, a report series written especially for those interested in BioMEMS and Nanomedicine. The Bourne Report offers the most insightful analysis available on emerging technologies, with a focus on MEMS and Nanotechnology. To subscribe to The Bourne Report, or for more information about Bourne Research, please visit: www.bourneresearch.com or contact Marlene Bourne at 480-695-0521.

About Bourne Research
Bourne Research is a trusted source of market intelligence, with a specialized focus on MEMS (MicroElectroMechanical Systems), Nanotechnology, and the convergence of both. Its founder, Marlene Bourne, is a highly respected industry analyst with more than a decade of experience following the development of emerging technologies, and is internationally recognized as one of the leading experts on MEMS.

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Marlene Bourne
Bourne Research LLC
480-695-0521
Email us Here
ATTACHED FILES

Bourne Research logo
Bourne Research logo

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright